In July 2023, the FDA gave full approval to Leqembi, the first-ever drug designed to slow the progression of Alzheimer’s disease. While the development and approval of this treatment represents a significant step forward in medical research – and tremendous hope for patients and their families – it might not be suited for everyone. Fortunately, there are additional resources to help those with Alzheimer’s disease and other forms of dementia.
The What & Who of Leqembi
Leqembi is a first-of-its-kind Alzheimer’s drug designed to identify and target disruptive beta-amyloid proteins in the body and help reduce existing amyloid brain plaque to slow the harmful impacts of the disease. In trials, the treatment was shown to slow cognitive decline by 27% over 18 months. “The impact that Leqembi may have on patients in the early stages of Alzheimer’s disease is potentially very great,” says Dr. Lynn Deutsch, a geriatric psychiatrist in Silver Spring, Maryland. “Leqembi has been shown to help clear the brain of the amyloid, which may prevent brain deterioration and subsequent severe stages of the illness.”
After earning accelerated approval from the FDA, Leqembi officially hit the market in 2023. However, the drug still isn’t widely available to those with Alzheimer’s and it’s only fit to treat people in the very early stages of the disease. In fact, only a quarter of the 6 million people currently living with Alzheimer’s in the U.S. will qualify for treatment with Leqembi, including those with mild forms of the disease and minor memory issues as opposed to more severe symptoms.
While drugs like Leqembi offer a major advancement in the treatment of Alzheimer’s and other progressive forms of dementia, it’s not a one size fits all. Adults living with dementia may need extra support, especially as the disease progresses. So, what is the next step as Alzheimer’s and dementia progresses? Home care can be an accessible and often vital resource for those living with this disease. “Treatment for patients in all stages of dementia includes not only medication but education and support of family and other caregivers,” adds Dr. Deutsch. “Caregivers and family play a significant role in the care of patients and education about the specific kind of dementia and caregiving techniques have been found to be effective in reducing patient agitation.”
The Family & Nursing Care Difference
Family & Nursing Care is a longtime leader in providing access to best-in-class care for older adults living with dementia and other cognitive issues, so they can feel the most comfortable. Dementia care services available through Family & Nursing Care offer private, customizable care options that can allow family respite and time, while providing the necessary support and companionship for clients based on their individual needs. Access to Caregivers with a wealth of experience and training at different stages of dementia can be provided, including:
As the medical field marks a major milestone with the introduction of Leqembi, and as treatments continue to evolve and develop, those dealing with dementia and their families can take comfort knowing more options exist, including home care, to help combat this disease. To learn more about Family & Nursing Care’s Alzheimer’s and dementia care offerings, call us at 800-588-0517 or visit the Home Care and Alzheimer’s/Dementia webpage.